Peptide entry

SS-31

Research peptidePeptide

Also known as: Elamipretide, MTP-131, Bendavia

Evidence / context

Evidence: Emerging. Mitochondrial-support context is narrower than broad longevity marketing implies.

Available vial formats

SS-31
Vial 10 mgMix 2.0 mLConc 5 mg/mL
  • Conservative 2 mg once daily (40 units per injection)
  • Standard 5 mg once daily (100 units per injection) or 5 mg per injection 5x/week
  • Aggressive 10 mg per injection, 3x/week (200 units per injection) only if the format and tolerance clearly fit
  • Cycle length 4-8 weeks
  • Best timing Morning or early afternoon; consistency matters more than exact clock time.

Reconstitution

  1. Swab vial tops with alcohol
  2. Draw 2.0 mL bacteriostatic water
  3. Inject slowly down vial wall (don't blast powder)
  4. Gently swirl - do not shake
  5. Rest 5-10 min to dissolve
  6. Refrigerate 2-8 C

Dosing, cycle & timing

Timing: Use as a steady block and avoid late dosing if it affects sleep.

Support / expected effects

Side effects / tolerability

Notes

Practical tips

Storage

Refrigerated: ~30-45 days after reconstitution.

Calculate the exact draw for SS-31Preloads your vial and water amount into the calculator.
Open calculator

Related peptides

Related goal guides

Related categories

FAQ

What is SS-31 explored for?

Mitochondrial membrane support and oxidative-stress support. May support energy resilience and exercise recovery. May reduce fatigue perception in some settings.

How is SS-31 reconstituted?

1) Swab vial tops with alcohol 2) Draw 2.0 mL bacteriostatic water 3) Inject slowly down vial wall (don't blast powder) 4) Gently swirl - do not shake 5) Rest 5-10 min to dissolve 6) Refrigerate 2-8 C

What is a typical cycle length for SS-31?

4-8 weeks

How are doses measured in syringe units here?

Units mean U-100 insulin-syringe gradations (1 mL = 100 units), not International Units. Use the calculator to convert a dose into the exact draw for your vial and water amount.

Save this protocolPrintable protocol sheet coming soon.